Healthcare provider profile · identity verified

Max John Pitlosh, M.D.

Family Practice · CHICAGO, IL · NPI 1760454904

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Baclofen	Baclofen	333	42
Atorvastatin Calcium	Atorvastatin Calcium	274	81
Famotidine	Famotidine	198	27
Lisinopril	Lisinopril	191	55
Rosuvastatin Calcium	Rosuvastatin Calcium	169	56
Omeprazole	Omeprazole	168	35
Amlodipine Besylate	Amlodipine Besylate	156	51
Metformin Hcl	Metformin Hcl	156	49
Levothyroxine Sodium	Levothyroxine Sodium	155	36
Levetiracetam	Levetiracetam	144	11
Tamsulosin Hcl	Tamsulosin Hcl	119	36
Losartan Potassium	Losartan Potassium	115	32
Lamotrigine	Lamotrigine	108	suppressed
Metoprolol Succinate	Metoprolol Succinate	107	31
Clonazepam	Clonazepam	101	16
Diazepam	Diazepam	99	15
Fluticasone Propionate	Fluticasone Propionate	93	25
Gabapentin	Gabapentin	93	28
Tramadol Hcl	Tramadol Hcl	84	16
Ozempic	Semaglutide	81	18
Pantoprazole Sodium	Pantoprazole Sodium	78	15
Albuterol Sulfate	Albuterol Sulfate	77	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	77	15
Montelukast Sodium	Montelukast Sodium	76	17
Tizanidine Hcl	Tizanidine Hcl	74	11
Hydrochlorothiazide	Hydrochlorothiazide	72	26
Furosemide	Furosemide	70	12
Simvastatin	Simvastatin	69	14
Carvedilol	Carvedilol	67	12
Potassium Chloride	Potassium Chloride	65	suppressed
Lactulose	Lactulose	62	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	61	suppressed
Alprazolam	Alprazolam	58	17
Spironolactone	Spironolactone	55	suppressed
Lorazepam	Lorazepam	54	11
Azelastine Hcl	Azelastine Hcl	52	suppressed
Allopurinol	Allopurinol	50	14
Chlorhexidine Gluconate	Chlorhexidine Gluconate	50	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	48	14
Topiramate	Topiramate	48	suppressed
Nortrel	Norethindrone-Ethin. Estradiol	47	suppressed
Prednisone	Prednisone	47	14
Phenobarbital	Phenobarbital	46	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	11
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	43	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	42	suppressed
Glipizide Er	Glipizide	42	13
Duloxetine Hcl	Duloxetine Hcl	40	11
Nystatin	Nystatin	40	14
Ibuprofen	Ibuprofen	38	11
Metformin Hcl Er	Metformin Hcl	37	11
Scopolamine	Scopolamine	37	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	16
Xarelto	Rivaroxaban	37	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Trazodone Hcl	Trazodone Hcl	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	12
Finasteride	Finasteride	32	11
Jardiance	Empagliflozin	32	suppressed
Primidone	Primidone	32	suppressed
Eliquis	Apixaban	31	suppressed
Risperidone	Risperidone	31	suppressed
Rybelsus	Semaglutide	31	suppressed
Glipizide	Glipizide	30	suppressed
Sertraline Hcl	Sertraline Hcl	29	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Temazepam	Temazepam	27	suppressed
Clopidogrel	Clopidogrel Bisulfate	26	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Carbamazepine	Carbamazepine	25	suppressed
Carisoprodol	Carisoprodol	25	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	25	suppressed
Clobazam	Clobazam	24	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	24	suppressed
Budesonide	Budesonide	23	suppressed
Lacosamide	Lacosamide	23	suppressed
Pregabalin	Pregabalin	23	suppressed
Methylprednisolone	Methylprednisolone	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Ketoconazole	Ketoconazole	21	15
Meloxicam	Meloxicam	21	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Lidocaine	Lidocaine	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Atenolol	Atenolol	18	suppressed
Colchicine	Colchicine	18	suppressed
Hydrocortisone	Hydrocortisone	18	11
Alyacen	Norethindrone-Ethin. Estradiol	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	14
Blisovi Fe	Norethindrone-E.Estradiol-Iron	17	suppressed
Cryselle	Norgestrel-Ethinyl Estradiol	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Low-Ogestrel	Norgestrel-Ethinyl Estradiol	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Febuxostat	Febuxostat	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	15	15
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	13
Tecfidera	Dimethyl Fumarate	15	suppressed
Azithromycin	Azithromycin	14	12
Clonidine Hcl	Clonidine Hcl	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ciclopirox	Ciclopirox Olamine	13	suppressed
Citalopram Hbr	Citalopram Hydrobromide	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Valsartan	Valsartan	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Dantrolene Sodium	Dantrolene Sodium	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Glycopyrrolate	Glycopyrrolate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	12	suppressed
Zirgan	Ganciclovir	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error